تأثیر آموزش گروهی فعال‌سازی رفتاری خانواده‌محور بر علائم روان‌شناختی بیماران مبتلا به مولتیپل اسکلروزیس

نوع مقاله : مقاله پژوهشی

نویسندگان

1 Department of Health Psychology, Kish International Branch, Islamic Azad University, Kish Island, Iran.

2 Department of Psychology, Torbat–e Jam Branch, Islamic Azad University, Torbat–e Jam, Iran.

3 Department of Psychology, Karaj Branch, Islamic Azad University, Karaj, Iran.

10.22038/jfmh.2024.82354.3164

چکیده

مقدمه: هدف ما بررسی تأثیر آموزش گروهی فعال سازی رفتاری خانواده محور بر علائم روانشناختی بیماران مبتلا به مولتیپل اسکلروزیس (MS) بود.
روش‌ کار: در این مطالعه 40 بیمار مبتلا به ام اس در شهرستان تربت جام در سال 1403-1402 به روش نمونه‌گیری در دسترس انتخاب و به‌طور تصادفی در دو گروه آزمون و شاهد قرار گرفتند. گروه آزمایش 8 جلسه 90 دقیقه ای آموزش فعال سازی رفتاری خانواده محور به مدت 3 ماه دریافت کردند. از مقیاس استرس اضطراب افسردگی 21 (DASS-21) استفاده شد و داده ها با استفاده از تحلیل واریانس با اندازه گیری مکرر تحلیل شدند.
 یافته‌ها: پس از مداخله، در گروه آزمون در مقایسه با گروه شاهد، تفاوت معنی‌داری در افسردگی (01/0> P)، اضطراب (01/0> P) و استرس (01/0> P) وجود داشت.
نتیجه‌گیری: با توجه به نتایج، آموزش فعال‌سازی رفتاری خانواده‌محور باعث کاهش علائم روان‌شناختی در بیماران ام‌اس می‌شود. بنابراین فعال سازی رفتاری مداخله ای موثر برای بهبود سلامت روان بیماران ام اس است و می تواند در مراقبت های استاندارد این بیماران ادغام شود.

کلیدواژه‌ها

مراجع

  1. Lorefice L, D’Alterio MN, Firinu D, Fenu G, Cocco E. Impact of menopause in patients with multiple sclerosis: Current perspectives. Int J Womens Health 2023; 15: 103-9.
  2. Maciak K, Dziedzic A, Saluk J. Possible role of the NLRP3 inflammasome and the gut–brain axis in multiple sclerosis‐related depression. FASEB J 2023; 37(1): e22687.
  3. Marck CH, Learmonth YC, Chen J, van der Mei I. Physical activity, sitting time and exercise types, and associations with symptoms in Australian people with multiple sclerosis. Disabil Rehabil 2022; 44(8): 1380-8.
  4. Samari B, Sadeghian E, Sattari M, Aghaie B. [Explaining the dimensions of specific competence in training specialist nurses in multiple sclerosis: A qualitative study]. Frontiers of nursing 2022; 9(3): 311-7. (Persian)
  5. Karhula ME, Kanelisto K, Hämäläinen P, Ruutiainen J, Era P, Häkkinen A, et al. Self-reported reasons for changes in performance of daily activities during a 2-year multidisciplinary multiple sclerosis rehabilitation. Int J MS Care 2022; 24(3): 110-16.
  6. Efendi H, Ünal A, Akçalı A, Altunan B, Bingöl A, Altunrende B, et al. The effect of cognitive performance on self-management behavior of multiple sclerosis patients. Mult Scler Relat Disord 2022; 63: 103880.
  7. AlSaeed S, Aljouee T, Alkhawajah NM, Alarieh R, AlGarni H, Aljarallah S, et al. Fatigue, depression, and anxiety among ambulating multiple sclerosis patients. Front Immunol 2022; 13: 844461.
  8. Carvalho T, Gomes C, Rodrigues A, da Motta C. Neuropathic pain, cognitive fusion, and alexithymia in patients with multiple sclerosis: Cross-sectional evidence for an explanatory model of anxiety symptoms. J Clin Psychol 2023; 79(5): 1342-56.
  9. Yu C, Ruan Y, Sun X, Chen C, Shen T, Liu C, et al. rTMS ameliorates depression/anxiety-like behaviors in experimental autoimmune encephalitis by inhibiting neurotoxic reactive astrocytes. J Affect Disord 2023; 331: 352-61.
  10. Hosseini Z, Homayuni A, Ghanbarnejad A. Determinants of stress coping behaviors in patients with Multiple Sclerosis (MS-DSCB): development and psychometrics of a PRECEDE model-based questionnaire. BMC Psychiatry 2022; 22(1): 578.
  11. Brenner R, Witzig-Brändli V, Vetsch J, Kohler M. Nursing interventions focusing on self-efficacy for patients with multiple sclerosis in rehabilitation: A systematic review. Int J MS Care 2022; 24(4): 189-98.
  12. Whittenbury K, Kroll L, Dubicka B, Bull ER. Exploring barriers and facilitators for mental health professionals delivering behavioural activation to young people with depression: Qualitative study using the Theoretical Domains Framework. BJPsych Open 2022; 8(2): e38.
  13. Kokubun K, Yamakawa Y, Nemoto K. The link between the brain volume-derived index and the determinants of social performance. Current psychology 2023; 42(15): 12309-21.
  14. Gum AM, Jensen C, Schonfeld L, Conner KO, Guerra L. A pilot study of brief, stepped behavioral activation for primary care patients with depressive symptoms. J Clin Psychol Med Settings 2023; 30(1): 17-27.
  15. Ali AM, Alkhamees AA, Hori H, Kim Y, Kunugi H. The depression anxiety stress scale 21: Development and validation of the depression anxiety stress scale 8-item in psychiatric patients and the general public for easier mental health measurement in a post COVID-19 world. Int J Environ Res Public Health 2021; 18(19): 10142.
  16. Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005; 44(2): 227-39.
  17. Kanter JW, Busch AM, Rusch LC. [Behavioral activation distinctive features]. Mirzaei M, Fereidouni S. (translators). Tehran: Arjmand; 2021. (Persian)
  18. Pellas J, Renner F, Ji JL, Damberg M. Telephone-based behavioral activation with mental imagery for depression: A pilot randomized clinical trial in isolated older adults during the Covid-19 pandemic. Int J Geriatr Psychiatry 2022; 37(1): 10.1002/gps.5646.
  19. Colombo D, Suso-Ribera C, Ortigosa-Beltrán I, Fernández-Álvarez J, García-Palacios A, Botella C. Behavioral activation through virtual reality for depression: A single case experimental design with multiple baselines. J Clin Med 2022; 11(5): 1262.
  20. Hosseini Z, Homayuni A, Etemadifar M. Barriers to quality of life in patients with multiple sclerosis: A qualitative study. BMC Neurology 2022; 22(1): 174.
  21. Egede LE, Davidson TM, Knapp RG, Walker RJ, Williams JS, Dismuke CE, et al. HOME DM-BAT: Home-based diabetes-modified behavioral activation treatment for low-income seniors with type 2 diabetes-study protocol for a randomized controlled trial. Trials 2021; 22(1): 787.
  22. Mohr DC, Hart SL, Julian L, Catledge C, Honos-Webb L, Vella L, et al. Telephone-administered psychotherapy for depression. Arch Gen Psychiatry 2005; 62(9): 1007-14.
  23. Thomas S, Thomas PW, Kersten P, Jones R, Green C, Nock A, et al. A pragmatic parallel arm multi-centre randomized controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 2013; 84(10): 1092-9.
  24. Hartmann M, Kopke S, Scherer P, Stangel M, Stellmann JP, Calabrese P, et al. Lessons learnt from a family-centred psychoeducational intervention for patients with multiple sclerosis and their caregivers. Patient Educ Couns 2014; 95(1): 98-105.
  25. Gawrysiak M, Nicholas C, Hopko DR. Behavioral activation for moderately depressed university students: Randomized controlled trial. J Couns Psychol 2009; 56(3): 468-75.
  26. Turner AP, Hartoonian N, Hughes AJ, Arewasikporn A, Alschuler KN, Sloan AP, et al. Physical activity and depression in MS: The mediating role of behavioral activation. Disabil Health J 2019; 12(4): 635-40.
  27. von Drathen S, Gold SM, Peper J, Rahn AC, Ramien C, Magyari M, et al. Stress and multiple sclerosis- Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progression. Brain Behav Immun 2024; 120: 620-29.
  28. Bal VH, Wilkinson E, Glascock V, Hastings RP, Jahoda A. Mechanisms of change in behavioral activation: Adapting depression treatment for autistic people. Cogn Behav Pract 2023; 30(4):589-96.
  29. Pott S L, Delgadillo J, Kellett. Is behavioral activation an effective and acceptable treatment for co-occurring depression and substance use disorders? A meta -analysis of randomized controlled trials. J Subst Abuse Treat 2022; 132: 108478.

 

مجله اصول بهداشت روانی
دوره 26، شماره 6
آذر و دی 1403
صفحه 399-405

فایل ها

هم رسانی

ارجاع به این مقاله

آمار